Cooperative action of the prostacyclin analogue taprostene and the fibrinolytic prourokinase (r-scu-PA) in experimental artery thrombosis.
Groves
R
R
Grünenthal GmbH, Center of Research, Aachen, FRG.
Schneider
J
J
Flohé
L
L
D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D002341:Carotid Artery Thrombosis / Q000188:drug therapy* / Q000503:physiopathology; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D011464:Epoprostenol / Q000008:administration & dosage* / Q000031:analogs & derivatives; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D008297:Male; D010960:Plasminogen Activators / Q000008:administration & dosage*; D011465:Prostaglandins, Synthetic / Q000008:administration & dosage; D011817:Rabbits; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*
D005343:Fibrinolytic Agents; D011465:Prostaglandins, Synthetic; C039188:taprostene; D011464:Epoprostenol; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator